Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-11

FDA Approved: TOBRAMYCIN AND DEXAMETHASONE — Original Application (Padagis US LLC)

View source ↗

Summary

The FDA approved Padagis US LLC's generic Tobramycin and Dexamethasone ophthalmic suspension as an original ANDA for treatment of inflammation and infection of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBRAMYCIN AND DEXAMETHASONE (tobramycin and dexamethasone)

Snippet

ORIG AP for TOBRAMYCIN AND DEXAMETHASONE (TOBRAMYCIN AND DEXAMETHASONE)